Guided Therapeutics (GTHP) Gross Profit Growth (3y) (2015 - 2025)
Guided Therapeutics (GTHP) Gross Profit Growth (3y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 9.77% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 12.24% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 4.81% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 14.82% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 9.36% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 14.95% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 3.96% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 3.99% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 8.95% |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 98.30% |
| Sep 30, 2025 | 126.80% |
| Jun 30, 2025 | 170.31% |
| Dec 31, 2024 | -27.01% |
| Dec 31, 2023 | -42.69% |
| Sep 30, 2023 | -27.27% |
| Jun 30, 2023 | 56.50% |
| Dec 31, 2022 | -104.75% |
| Sep 30, 2022 | 44.22% |
| Jun 30, 2022 | 27.29% |
| Mar 31, 2022 | -38.26% |
| Dec 31, 2021 | 43.12% |
| Sep 30, 2021 | -138.11% |
| Jun 30, 2021 | -34.14% |
| Dec 31, 2020 | 33.38% |
| Sep 30, 2020 | 44.47% |
| Jun 30, 2020 | -47.36% |
| Dec 31, 2019 | 27.31% |
| Sep 30, 2019 | -53.58% |
| Jun 30, 2019 | -38.67% |